Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
ABT Abbott Laboratories
- Stocks
- Healthcare
- NYSE: ABT
Price (delayed)
$131.99
Market cap
$229.64B
P/E Ratio
17.1
Dividend/share
$2.28
EPS
$7.72
Enterprise value
$236.35B
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott
Highlights
Abbott Laboratories's net income has surged by 140% YoY
The EPS has soared by 139% YoY
Key stats
What are the main financial stats of ABT
Market
Valuations
Earnings
Shares outstanding
1.74B
Market cap
$229.64B
Enterprise value
$236.35B
Price to earnings (P/E)
17.1
Price to book (P/B)
4.67
Price to sales (P/S)
5.42
EV/EBIT
29.9
EV/EBITDA
21.34
EV/Sales
5.58
Revenue
$42.34B
Gross profit
$23.63B
Operating income
$7.13B
Net income
$13.5B
EBIT
$7.9B
EBITDA
$11.07B
Free cash flow
$6.66B
Per share
Balance sheet
Liquidity
EPS
$7.72
EPS diluted
$7.7
Free cash flow per share
$3.83
Book value per share
$28.29
Revenue per share
$24.35
TBVPS
$29.8
Total assets
$81.45B
Total liabilities
$32.38B
Debt
$13.24B
Equity
$49.06B
Working capital
$10.15B
Debt to equity
0.27
Current ratio
1.78
Quick ratio
1.09
Net debt/EBITDA
0.61
Margins
Efficiency
Dividend
EBITDA margin
26.2%
Gross margin
55.8%
Net margin
31.9%
Operating margin
16.8%
Return on assets
17.4%
Return on equity
30.6%
Return on invested capital
19.6%
Return on capital employed
11.5%
Return on sales
18.7%
Dividend yield
1.73%
DPS
$2.28
Payout ratio
29.5%
ABT stock price
How has the Abbott Laboratories stock price performed over time
Intraday
-0.94%
1 week
-0.46%
1 month
4.03%
1 year
26.02%
YTD
16.69%
QTD
-0.5%
Financial performance
How have Abbott Laboratories's revenue and profit performed over time
Revenue
$42.34B
Gross profit
$23.63B
Operating income
$7.13B
Net income
$13.5B
Gross margin
55.8%
Net margin
31.9%
Abbott Laboratories's net income has surged by 140% YoY
Abbott Laboratories's net margin has surged by 128% YoY
The operating income has grown by 12% YoY and by 4.5% from the previous quarter
Abbott Laboratories's operating margin has increased by 6% YoY and by 3.1% from the previous quarter
Price vs fundamentals
How does ABT's price correlate with its fundamentals
Growth
What is Abbott Laboratories's growth rate over time
Valuation
What is Abbott Laboratories stock price valuation
P/E
17.1
P/B
4.67
P/S
5.42
EV/EBIT
29.9
EV/EBITDA
21.34
EV/Sales
5.58
The EPS has soared by 139% YoY
ABT's P/E is 48% below its 5-year quarterly average of 32.7 and 31% below its last 4 quarters average of 24.8
ABT's equity is up by 26% year-on-year and by 2.4% since the previous quarter
ABT's price to book (P/B) is 12% lower than its 5-year quarterly average of 5.3
ABT's P/S is 11% above its 5-year quarterly average of 4.9 and 11% above its last 4 quarters average of 4.9
The revenue has grown by 5% YoY
Efficiency
How efficient is Abbott Laboratories business performance
Abbott Laboratories's return on assets has surged by 126% YoY but it has decreased by 2.2% QoQ
ABT's ROE has soared by 108% YoY but it is down by 5% from the previous quarter
The ROS has grown by 5% YoY and by 3.3% from the previous quarter
The ROIC has contracted by 4.4% YoY and by 2.5% from the previous quarter
Dividends
What is ABT's dividend history
DPS
$2.28
Dividend yield
1.73%
Payout ratio
29.5%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Abbott Laboratories financials performed over time
The total assets is 152% more than the total liabilities
ABT's quick ratio is up by 15% year-on-year and by 3.8% since the previous quarter
The total assets has grown by 12% YoY
Abbott Laboratories's debt is 73% lower than its equity
Abbott Laboratories's debt to equity has decreased by 27% YoY and by 7% from the previous quarter
ABT's equity is up by 26% year-on-year and by 2.4% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.